251 related articles for article (PubMed ID: 34215932)
1. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.
Xie M; Pei DS
Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932
[TBL] [Abstract][Full Text] [Related]
2. SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells.
Zhang Y; Liu Z; Wang X; Jian H; Xiao H; Wen T
Cancer Gene Ther; 2022 Oct; 29(10):1514-1527. PubMed ID: 35422087
[TBL] [Abstract][Full Text] [Related]
3. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.
Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312
[TBL] [Abstract][Full Text] [Related]
4. Serine catabolism regulates mitochondrial redox control during hypoxia.
Ye J; Fan J; Venneti S; Wan YW; Pawel BR; Zhang J; Finley LW; Lu C; Lindsten T; Cross JR; Qing G; Liu Z; Simon MC; Rabinowitz JD; Thompson CB
Cancer Discov; 2014 Dec; 4(12):1406-17. PubMed ID: 25186948
[TBL] [Abstract][Full Text] [Related]
5. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
[TBL] [Abstract][Full Text] [Related]
6. Vital role of SHMT2 in diverse disease.
Ma W; Liu R; Zhao K; Zhong J
Biochem Biophys Res Commun; 2023 Sep; 671():160-165. PubMed ID: 37302290
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control of BRISC-SHMT2 assembly regulates immune signalling.
Walden M; Tian L; Ross RL; Sykora UM; Byrne DP; Hesketh EL; Masandi SK; Cassel J; George R; Ault JR; El Oualid F; Pawłowski K; Salvino JM; Eyers PA; Ranson NA; Del Galdo F; Greenberg RA; Zeqiraj E
Nature; 2019 Jun; 570(7760):194-199. PubMed ID: 31142841
[TBL] [Abstract][Full Text] [Related]
8. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
9. Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.
Marrocco I; Altieri F; Rubini E; Paglia G; Chichiarelli S; Giamogante F; Macone A; Perugia G; Magliocca FM; Gurtner A; Maras B; Ragno R; Patsilinakos A; Manganaro R; Eufemi M
Cells; 2019 Sep; 8(9):. PubMed ID: 31500219
[TBL] [Abstract][Full Text] [Related]
10. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
Wang Q; Tian J; Li X; Liu X; Zheng T; Zhao Y; Li X; Zhong H; Liu D; Zhang W; Zhang M; Li M; Zhang M
Hypertension; 2022 May; 79(5):960-973. PubMed ID: 35249365
[TBL] [Abstract][Full Text] [Related]
12. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.
Kim D; Fiske BP; Birsoy K; Freinkman E; Kami K; Possemato RL; Chudnovsky Y; Pacold ME; Chen WW; Cantor JR; Shelton LM; Gui DY; Kwon M; Ramkissoon SH; Ligon KL; Kang SW; Snuderl M; Vander Heiden MG; Sabatini DM
Nature; 2015 Apr; 520(7547):363-7. PubMed ID: 25855294
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress-dependent regulation of the expression of serine hydroxymethyltransferase 2 in glioblastoma cells.
Minchenko OH; Sliusar MY; Khita OO; Viletska YM; Luzina OY; Danilovskyi SV; Minchenko DO
Endocr Regul; 2024 Jan; 58(1):144-152. PubMed ID: 38861539
[No Abstract] [Full Text] [Related]
15. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
16. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
[TBL] [Abstract][Full Text] [Related]
17. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
Parsa S; Ortega-Molina A; Ying HY; Jiang M; Teater M; Wang J; Zhao C; Reznik E; Pasion JP; Kuo D; Mohan P; Wang S; Camarillo JM; Thomas PM; Jain N; Garcia-Bermudez J; Cho BK; Tam W; Kelleher NL; Socci N; Dogan A; De Stanchina E; Ciriello G; Green MR; Li S; Birsoy K; Melnick AM; Wendel HG
Nat Cancer; 2020; 1():653-664. PubMed ID: 33569544
[TBL] [Abstract][Full Text] [Related]
18. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties.
Tramonti A; Nardella C; di Salvo ML; Barile A; Cutruzzolà F; Contestabile R
Biochemistry; 2018 Dec; 57(51):6984-6996. PubMed ID: 30500180
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition.
Chen L; Liu H; Ji Y; Ma Z; Shen K; Shangguan X; Qian H; Zhao Y; Pan CW; Xue W
Exp Cell Res; 2022 Jun; 415(2):113138. PubMed ID: 35398308
[TBL] [Abstract][Full Text] [Related]
20. Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs.
Minton DR; Nam M; McLaughlin DJ; Shin J; Bayraktar EC; Alvarez SW; Sviderskiy VO; Papagiannakopoulos T; Sabatini DM; Birsoy K; Possemato R
Mol Cell; 2018 Feb; 69(4):610-621.e5. PubMed ID: 29452640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
